231 related articles for article (PubMed ID: 26320409)
1. Complexity of cancer protease biology: Cathepsin K expression and function in cancer progression.
Verbovšek U; Van Noorden CJ; Lah TT
Semin Cancer Biol; 2015 Dec; 35():71-84. PubMed ID: 26320409
[TBL] [Abstract][Full Text] [Related]
2. Cathepsin K in melanoma invasion.
Quintanilla-Dieck MJ; Codriansky K; Keady M; Bhawan J; Rünger TM
J Invest Dermatol; 2008 Sep; 128(9):2281-8. PubMed ID: 18368130
[TBL] [Abstract][Full Text] [Related]
3. Targeting cathepsin K diminishes prostate cancer establishment and growth in murine bone.
Liang W; Wang F; Chen Q; Dai J; Escara-Wilke J; Keller ET; Zimmermann J; Hong N; Lu Y; Zhang J
J Cancer Res Clin Oncol; 2019 Aug; 145(8):1999-2012. PubMed ID: 31172267
[TBL] [Abstract][Full Text] [Related]
4. Expression and regulation of cathepsin K in skin fibroblasts.
Quintanilla-Dieck MJ; Codriansky K; Keady M; Bhawan J; Rünger TM
Exp Dermatol; 2009 Jul; 18(7):596-602. PubMed ID: 19469903
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of a cathepsin K inhibitor in a preclinical model for prevention and treatment of breast cancer bone metastasis.
Duong LT; Wesolowski GA; Leung P; Oballa R; Pickarski M
Mol Cancer Ther; 2014 Dec; 13(12):2898-909. PubMed ID: 25249554
[TBL] [Abstract][Full Text] [Related]
6. Cathepsin K is present in invasive oral tongue squamous cell carcinoma in vivo and in vitro.
Bitu CC; Kauppila JH; Bufalino A; Nurmenniemi S; Teppo S; Keinänen M; Vilen ST; Lehenkari P; Nyberg P; Coletta RD; Salo T
PLoS One; 2013; 8(8):e70925. PubMed ID: 23951042
[TBL] [Abstract][Full Text] [Related]
7. Sequential, but not Concurrent, Incubation of Cathepsin K and L with Type I Collagen Results in Extended Proteolysis.
Parks AN; Nahata J; Edouard NE; Temenoff JS; Platt MO
Sci Rep; 2019 Apr; 9(1):5399. PubMed ID: 30931961
[TBL] [Abstract][Full Text] [Related]
8. Altered hematopoietic stem cell and osteoclast precursor frequency in cathepsin K null mice.
Jacome-Galarza C; Soung do Y; Adapala NS; Pickarski M; Sanjay A; Duong LT; Lorenzo JA; Drissi H
J Cell Biochem; 2014 Aug; 115(8):1449-57. PubMed ID: 24590570
[TBL] [Abstract][Full Text] [Related]
9. Structural requirements for the collagenase and elastase activity of cathepsin K and its selective inhibition by an exosite inhibitor.
Sharma V; Panwar P; O'Donoghue AJ; Cui H; Guido RV; Craik CS; Brömme D
Biochem J; 2015 Jan; 465(1):163-73. PubMed ID: 25279554
[TBL] [Abstract][Full Text] [Related]
10. Identification of mouse cathepsin K structural elements that regulate the potency of odanacatib.
Law S; Andrault PM; Aguda AH; Nguyen NT; Kruglyak N; Brayer GD; Brömme D
Biochem J; 2017 Feb; 474(5):851-864. PubMed ID: 28049758
[TBL] [Abstract][Full Text] [Related]
11. Cathepsin K gene disruption does not affect murine aneurysm formation.
Bai L; Beckers L; Wijnands E; Lutgens SP; Herías MV; Saftig P; Daemen MJ; Cleutjens K; Lutgens E; Biessen EA; Heeneman S
Atherosclerosis; 2010 Mar; 209(1):96-103. PubMed ID: 19775691
[TBL] [Abstract][Full Text] [Related]
12. Cathepsin K expression and activity in canine osteosarcoma.
Schmit JM; Pondenis HC; Barger AM; Borst LB; Garrett LD; Wypij JM; Neumann ZL; Fan TM
J Vet Intern Med; 2012; 26(1):126-34. PubMed ID: 22171552
[TBL] [Abstract][Full Text] [Related]
13. Cathepsin K inhibitors as treatment of bone metastasis.
Le Gall C; Bonnelye E; Clézardin P
Curr Opin Support Palliat Care; 2008 Sep; 2(3):218-22. PubMed ID: 18685424
[TBL] [Abstract][Full Text] [Related]
14. Cathepsin K in Pathological Conditions and New Therapeutic and Diagnostic Perspectives.
Mijanović O; Jakovleva A; Branković A; Zdravkova K; Pualic M; Belozerskaya TA; Nikitkina AI; Parodi A; Zamyatnin AA
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430239
[TBL] [Abstract][Full Text] [Related]
15. Cathepsin K Controls Cortical Bone Formation by Degrading Periostin.
Bonnet N; Brun J; Rousseau JC; Duong LT; Ferrari SL
J Bone Miner Res; 2017 Jul; 32(7):1432-1441. PubMed ID: 28322464
[TBL] [Abstract][Full Text] [Related]
16. Investigation of osteoclast cathepsin K activity in osteoclastogenesis and bone loss using a set of chemical reagents.
Janiszewski T; Kołt S; Ciastoń I; Vizovisek M; Poręba M; Turk B; Drąg M; Kozieł J; Kasperkiewicz P
Cell Chem Biol; 2023 Feb; 30(2):159-174.e8. PubMed ID: 36696904
[TBL] [Abstract][Full Text] [Related]
17. Proteases as prognostic markers in human and canine cancers.
Pulz LH; Strefezzi RF
Vet Comp Oncol; 2017 Sep; 15(3):669-683. PubMed ID: 27136601
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and biological evaluation of inhibitors of cathepsin K on dedifferentiated chondrocytes.
Yuan XY; Ren Z; Wu Y; Bougault C; Brizuela L; Magne D; Buchet R; Mebarek S
Bioorg Med Chem; 2019 Mar; 27(6):1034-1042. PubMed ID: 30773420
[TBL] [Abstract][Full Text] [Related]
19. Modulation of lentiviral vector tropism in cerebellar Purkinje cells in vivo by a lysosomal cysteine protease cathepsin K.
Goenawan H; Hirai H
J Neurovirol; 2012 Dec; 18(6):521-31. PubMed ID: 23070819
[TBL] [Abstract][Full Text] [Related]
20. Optical visualization of cathepsin K activity in atherosclerosis with a novel, protease-activatable fluorescence sensor.
Jaffer FA; Kim DE; Quinti L; Tung CH; Aikawa E; Pande AN; Kohler RH; Shi GP; Libby P; Weissleder R
Circulation; 2007 May; 115(17):2292-8. PubMed ID: 17420353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
